Singapore markets closed

ImmunityBio, Inc. (IBRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.61+0.19 (+2.96%)
At close: 04:00PM EDT
6.74 +0.13 (+1.93%)
Pre-market: 08:57AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1122
Avg. Estimate-0.17-0.16-0.74-0.52
Low estimate-0.17-0.16-0.84-0.62
High estimate-0.17-0.16-0.65-0.42
Year ago EPS-0.32-0.19-1.15-0.74
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1122
Avg. Estimate2.52M10.03M71.55M277.38M
Low estimate2.52M10.03M35.31M246.57M
High estimate2.52M10.03M107.8M308.2M
Year ago sales41k82k622k71.55M
Sales growth (year/est)6,046.30%12,131.70%11,403.20%287.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.23-0.25-0.18-0.16
Actual EPS-0.32-0.19-0.35-0.2
Difference-0.090.06-0.17-0.04
Surprise %-39.10%24.00%-94.40%-25.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.17-0.16-0.74-0.52
7 days ago-0.17-0.16-0.74-0.52
30 days ago-0.17-0.16-0.74-0.52
60 days ago-0.17-0.17-0.68-0.45
90 days ago-0.17-0.17-0.68-0.38
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesIBRXIndustrySector(s)S&P 500
Current qtr.46.90%N/AN/AN/A
Next qtr.15.80%N/AN/AN/A
Current year35.70%N/AN/AN/A
Next year29.70%N/AN/AN/A
Next 5 years (per annum)-1.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A